How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Document

    Do you agree NICE should focus on guidance production and maintenance on priority areas (section 5) and these should be reviewed periodically to ensure NICE is supporting what the health and care system needs? If you disagree, please give reason and rationale.

  • Question on Document

    Do you agree that NICE should be transparent about its remit (section 3.12, section 6.1.1 and 6.2)? If you disagree, please give reason and rationale.

  • Question on Document

    Do you think the new process and consideration factors for NICE to propose topics to the Secretary of State for NHAP are robust and transparent (section 4 and Annex A)? If you disagree, please give reason and rationale. Are there any other factors NICE should include to consider?

  • Question on Document

    Do you think the new merged single-stage prioritisation framework is more streamlined and efficient for topic selection? If you disagree, please give reason and rationale.

NICE-wide topic prioritisation: the manual

Open for comments Open until   Request commenting lead permission

We have updated this service so that members of the same organisation can now collaborate on a joint online response.

Read our blog to learn more.

11 NICE-wide topic prioritisation clarification process

The aim of the clarification process is to explain NICE's reason for its prioritisation decision(s), both positive and negative decisions, including technology appraisal selection decisions, that are queried by stakeholders. Requests for clarification do not usually offer an opportunity to revisit or overturn the NICE prioritisation boardhttps://www.nice.org.uk/Glossary?letter=P#Prioritisation%20board's decision, which is based on careful consideration of the evidence and relevance for future guidance development. Exceptions would be if substantial new information or factual errors come to light, or there is evidence that the highly specialised technologies routing criteria have not been appropriately applied for ultra rare diseases, or if the selection factors have not been appropriately considered for selecting HealthTech topics using the NICE technology appraisal process. In exceptional circumstances, NICE may change its decision on the routing of new topics or updates following input from stakeholders and will specify the rationale for this change.

If a prioritisation board decision is changed as a result of a clarification request, the amended decision will be published on the NICE website. This approach will apply to all topics and routing decisions that the prioritisation board considers.

Stakeholders should complete the clarification proforma within 20 working days of publication of the prioritisation board's decision. The questions will be reviewed, and a response will be provided within 20 working days of the questions being received.

If a stakeholder has further questions following an initial response, these should be submitted using the same proforma within 20 working days of receiving the response to their original clarification request. The additional questions will be reviewed and then considered by the NICE guidance executive. The guidance executive will produce a final response within 10 working days after the meeting.

Clarifications and any final response from the guidance executive will be sent directly to the stakeholder using a standard template. If there is a change to the original prioritisation board decision, this will be published on the NICE website.